Schedule 13G ownership disclosure
ORIC Pharmaceuticals Inc
Common Stock, par value $0.0001 per share · CUSIP: 68622P109
Event date: 2025-04-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Venrock Healthcare Capital Partners III, L.P.
Shares: 6,596,885.00 · Class: 7.7%
- VHCP Co-Investment Holdings III, LLC
Shares: 6,596,885.00 · Class: 7.7%
- Venrock Healthcare Capital Partners EG, L.P.
Shares: 6,596,885.00 · Class: 7.7%
- VHCP Management III, LLC
Shares: 6,596,885.00 · Class: 7.7%
- VHCP Management EG, LLC
Shares: 6,596,885.00 · Class: 7.7%
- Nimish Shah
Shares: 6,596,885.00 · Class: 7.7%
- Bong Y Koh
Shares: 6,596,885.00 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-015010
- Form type
- SCHEDULE 13G
- Filer
- Oric Pharmaceuticals, Inc.
- CIK
- CIK 1796280
- Filed
- May 30, 2025
- Reporting period
- Apr 08, 2025
- Description
- Schedule 13G beneficial ownership